http://orcid.org/0000-0002-8552-414X
Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ryan J. Watson, Cindy J. Chang, Brian A. Feinstein, Raymond L. Moody, Antonia Caba & Lisa A. Eaton. (2022) PrEP Stigma and logistical barriers remain significant challenges in curtailing HIV transmission among Black and Hispanic/Latinx cisgender sexual minority men and transgender women in the US. AIDS Care 34:11, pages 1465-1472.
Read now
Read now
Nioud Mulugeta Gebru, Maria Costanza Benvenuti, Bonnie H. P. Rowland, Meher Kalkat, Patricia G. Chauca & Robert F. Leeman. (2022) Relationships among Substance Use, Sociodemographics, Pre-Exposure Prophylaxis (PrEP) Awareness and Related Attitudes among Young Adult Men Who Have Sex with Men. Substance Use & Misuse 57:5, pages 786-798.
Read now
Read now
Articles from other publishers (35)
M Colten Staten, Alicia Webster & Gregory Carter. (2023) Do Ask, Do Tell: Understanding Disclosure of Sexuality and Implications Among MSM Active Duty Service Members. Military Medicine 188:7-8, pages 1656-1663.
Crossref
Crossref
Robert A. BonacciMichelle Van HandelRebecca HugginsSeidu InusahDawn K. Smith. (2023) Estimated Uncovered Costs For HIV Preexposure Prophylaxis In The US, 2018. Health Affairs 42:4, pages 546-555.
Crossref
Crossref
Nila J Dharan, Fengyi Jin, Stefanie Vaccher, Benjamin Bavinton, Barbara Yeung, Rebecca Guy, Andrew Carr, Iryna Zablotska, Janaki Amin, Philip Read, David J Templeton, Catriona Ooi, Sarah J Martin, Nathan Ryder, Don E Smith, Anna McNulty, Katherine Brown, Karen Price, Jo Holden, Andrew E Grulich, Rebecca Guy, Jeff Jin, Janaki Amin, Nila J Dharan, Iryna Zabloska, Stefanie Vaccher, Mo Hammoud, Kerry Chant, Jo Holden, Christine Selvey, Bill Whittaker, Heather-Maire Schmidt, Dale Halliday, Cherie Power, Karen Price, Nicolas Parkhill, Andrew Carr, Anna McNulty, Ben Anderson, Brad Forssman, Catriona Ooi, Christopher Carmody, Daniel Chanisheff, David Baker, David Lewis, David Smith, David J Templeton, David Townsend, Debra Allen, Don E Smith, Eva Jackson, Emanuel Vlahakis, Gia Han Thai, Hugh MacLeod, Josephine Lusk, Katherine Brown, Kym Collins, Mark Bloch, Nathan Ryder, Nicolas Doong, Phillip Read, Robert Finlayson, Sarah J Martin, Clara Tuck Meng Soo, Barbara Yeung, Erin Ogilvie, Gesalit Cabrera, Shawn Clackett, Toby Vickers & Lucy Watchirs Smith. (2023) Characteristics of Human Immunodeficiency Virus (HIV) Seroconversions in a Large Prospective Implementation Cohort Study of Oral HIV Preexposure Prophylaxis in Men Who Have Sex with Men (EPIC-NSW). Clinical Infectious Diseases 76:3, pages e622-e628.
Crossref
Crossref
Caroline Lions, Helene Laroche, Marion Mora, Gilles Pialoux, Laurent Cotte, Eric Cua, Lionel Piroth, Jean Michel Molina, Maria Salnikova, Gwenaëlle Maradan, Isabelle Poizot‐Martin & Bruno Spire. (2022)
Missed opportunities for
HIV
pre‐exposure prophylaxis among people with recent
HIV
infection: The French
ANRS
95041
OMaPrEP
study
. HIV Medicine 24:2, pages 191-201.
Crossref
Crossref
Rajesh T. Gandhi, Roger Bedimo, Jennifer F. Hoy, Raphael J. Landovitz, Davey M. Smith, Ellen F. Eaton, Clara Lehmann, Sandra A. Springer, Paul E. Sax, Melanie A. Thompson, Constance A. Benson, Susan P. Buchbinder, Carlos del Rio, Joseph J. EronJrJr, Huldrych F. Günthard, Jean-Michel Molina, Donna M. Jacobsen & Michael S. Saag. (2023) Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults. JAMA 329:1, pages 63.
Crossref
Crossref
Linda Beer, Yunfeng Tie, Sharoda Dasgupta, Timothy McManus, Dawn K. Smith & R. Luke Shouse. (2022) Trends in preexposure prophylaxis use among sex partners as reported by persons with HIV – United States, May 2015–June 2020. AIDS 36:15, pages 2161-2169.
Crossref
Crossref
Adam Viera, Jacob J. van den Berg, Collette D. Sosnowy, Nikita A. Mehta, E. Jennifer Edelman, Trace Kershaw & Philip A. Chan. (2022) Barriers and Facilitators to HIV Pre-Exposure Prophylaxis Uptake Among Men Who have Sex with Men Who Use Stimulants: A Qualitative Study. AIDS and Behavior 26:9, pages 3016-3028.
Crossref
Crossref
Trisha A. Miller, Katherine Halza & Zachary Hovis. (2022)
Implementation of
pharmacist‐led HIV pre‐exposure
prophylaxis management to increase access to care at an academic internal medicine practice
. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY 5:9, pages 988-994.
Crossref
Crossref
Brian A. Feinstein, Cindy J. Chang, Samuel R. Bunting, Jesse Bahrke, Aniruddha Hazra & Sarah S. Garber. (2022) Willingness to Prescribe PrEP to Bisexual Men Depends on Genders of Their Past Partners: A Study of Medical Students in the USA. Archives of Sexual Behavior 51:5, pages 2535-2547.
Crossref
Crossref
Christopher Calabrese, Jingwen Zhang & Xudong Yu. (2022) Perceptions of PrEP on Twitter: A Theoretically Guided Content Analysis on the Behavioral Determinants of PrEP Uptake. Health & New Media Research 6:1, pages 65-102.
Crossref
Crossref
Jessica T. Campbell, Olivia R. Adams, Margaret Bennett-Brown, Brennan Woodward, Amanda N. Gesselman & Gregory Carter. (2022) PrEP Familiarity, Interest, and Usage Among 364 Black and Hispanic Adults in Indiana. Frontiers in Public Health 10.
Crossref
Crossref
Kristen Whelchel, Autumn D. Zuckerman, Josh DeClercq, Leena Choi, Shahristan Rashid & Sean G. Kelly. (2022) HIV PrEP access and affordability: a multidisciplinary specialty pharmacy model. Journal of the American Pharmacists Association 62:3, pages 853-858.
Crossref
Crossref
Anne E. Sundelson, Étienne Meunier, Eric W. Schrimshaw & Karolynn Siegel. (2021) Barriers to Pre-Exposure Prophylaxis Uptake Among Online Male Sex Workers in the US. AIDS and Behavior 26:5, pages 1572-1586.
Crossref
Crossref
Penny S. Loosier, Kaytlin Renfro, Monique Carry, Samantha P. Williams, Matthew Hogben & Sevgi Aral. (2021) Reddit on PrEP: Posts About Pre-exposure Prophylaxis for HIV from Reddit Users, 2014–2019. AIDS and Behavior 26:4, pages 1084-1094.
Crossref
Crossref
Nina T. HarawaDiane TanArleen A. Leibowitz. (2022) Disparities In Uptake Of HIV Pre-Exposure Prophylaxis Among California Medicaid Enrollees. Health Affairs 41:3, pages 360-367.
Crossref
Crossref
Kimberly A. Koester, Xavier A. Erguera, Ifeoma Udoh, Mi-Suk Kang Dufour, Jeffrey H. Burack & Janet J. Myers. (2021) Exploring the Shift From HIV Pre-exposure Prophylaxis Awareness to Uptake Among Young Gay and Bisexual Men. Frontiers in Public Health 9.
Crossref
Crossref
Afiba Manza-A. Agovi, Ifedioranma Anikpo, Matthew J. Cvitanovich, Esther O. Fasanmi, Rohit P. Ojha & Julia L. Marcus. (2021) Brief Report: HIV Pre-exposure Prophylaxis Prescribing in an Urban Safety-Net Health System. JAIDS Journal of Acquired Immune Deficiency Syndromes 88:3, pages e17-e21.
Crossref
Crossref
Peter Liu, Leslie Stewart, William R. Short & Helen Koenig. (2021) Metrics of HIV Pre-exposure Prophylaxis (PrEP) Implementation Before and After a Multidisciplinary Task Force at an Academic Institution. Quality Management in Health Care Publish Ahead of Print.
Crossref
Crossref
J. Carlo Hojilla, Leo B. Hurley, Julia L. Marcus, Michael J. Silverberg, Jacek Skarbinski, Derek D. Satre & Jonathan E. Volk. (2021) Characterization of HIV Preexposure Prophylaxis Use Behaviors and HIV Incidence Among US Adults in an Integrated Health Care System. JAMA Network Open 4:8, pages e2122692.
Crossref
Crossref
Julia L Marcus, Kenneth Levine, Whitney C Sewell, Patricia Solleveld, Kenneth H Mayer & Douglas S Krakower. (2021) Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide for Human Immunodeficiency Virus Preexposure Prophylaxis at a Boston Community Health Center. Open Forum Infectious Diseases 8:8.
Crossref
Crossref
Christina Camp & Parya Saberi. (2021) Facilitators and barriers of 2-1-1 HIV pre-exposure prophylaxis. PLOS ONE 16:5, pages e0251917.
Crossref
Crossref
Amy R. BaugherTeresa FinlaysonRashunda LewisCatlainn SioneanAri WhitemanCyprian Wejnert. (2021) Health Care Coverage and Preexposure Prophylaxis (PrEP) Use Among Men Who Have Sex With Men Living in 22 US Cities With vs Without Medicaid Expansion, 2017. American Journal of Public Health 111:4, pages 743-751.
Crossref
Crossref
Whitney C. Sewell, Patricia Solleveld, Dominika Seidman, Christine Dehlendorf, Julia L. Marcus & Douglas S. Krakower. (2021) Patient-Led Decision-Making for HIV Preexposure Prophylaxis. Current HIV/AIDS Reports 18:1, pages 48-56.
Crossref
Crossref
J Carlo Hojilla, Julia L Marcus, Michael J Silverberg, C Bradley Hare, Rachel Herbers, Leo Hurley, Derek D Satre & Jonathan E Volk. (2020) Early Adopters of Event-driven Human Immunodeficiency Virus Pre-exposure Prophylaxis in a Large Healthcare System in San Francisco. Clinical Infectious Diseases 71:10, pages 2710-2712.
Crossref
Crossref
Drew A. WestmorelandAlexa D'AngeloDenis NashChristian Grov. (2020) Individual and Partner Characteristics Associated With Intentions to Use PrEP Among Partnered Men, Trans Men, and Trans Women in Sero-Concordant and -Discordant Relationships in the United States. AIDS Education and Prevention 32:5, pages 367-377.
Crossref
Crossref
Collette Sosnowy, Jun Tao, Hector Nunez, Madeline C Montgomery, Colleen D Ndoye, Katie Biello, Matthew J Mimiaga, Julia Raifman, Matthew Murphy, Amy Nunn, Michaela Maynard & Philip A Chan. (2020) Awareness and use of HIV pre-exposure prophylaxis among people who engage in sex work presenting to a sexually transmitted infection clinic. International Journal of STD & AIDS 31:11, pages 1055-1062.
Crossref
Crossref
Christopher Owens, Randolph D. Hubach, Deana Williams, Eva Voorheis, Jessica Lester, Michael Reece & Brian Dodge. (2020) Facilitators and Barriers of Pre-exposure Prophylaxis (PrEP) Uptake Among Rural Men who have Sex with Men Living in the Midwestern U.S.. Archives of Sexual Behavior 49:6, pages 2179-2191.
Crossref
Crossref
Matthew A Spinelli, Nicole Laborde, Patrick Kinley, Ryan Whitacre, Hyman M Scott, Nicole Walker, Albert Y Liu, Monica Gandhi & Susan P Buchbinder. (2020) The importance of PrEP persistence in preventing HIV infections on PrEP. Journal of the International AIDS Society 23:8.
Crossref
Crossref
Frank Kutscha, Matthew Gaskins, Mary Sammons, Alexander Nast & Ricardo Niklas Werner. (2020) HIV Pre-Exposure Prophylaxis (PrEP) Counseling in Germany: Knowledge, Attitudes and Practice in Non-governmental and in Public HIV and STI Testing and Counseling Centers. Frontiers in Public Health 8.
Crossref
Crossref
Whitney C. Sewell, Victoria E. Powell, Kenneth H. Mayer, Aileen Ochoa, Douglas S. Krakower & Julia L. Marcus. (2020) Nondaily Use of HIV Preexposure Prophylaxis in a Large Online Survey of Primarily Men Who Have Sex With Men in the United States. JAIDS Journal of Acquired Immune Deficiency Syndromes 84:2, pages 182-188.
Crossref
Crossref
Kenneth H. Mayer, Allison Agwu & David Malebranche. (2020) Barriers to the Wider Use of Pre-exposure Prophylaxis in the United States: A Narrative Review. Advances in Therapy 37:5, pages 1778-1811.
Crossref
Crossref
Patrick O’Byrne, Lauren Orser & Marlene Haines. (2019) Active-Offer Nurse-Led PrEP (PrEP-RN) Referrals: Analysis of Uptake Rates and Reasons for Declining. AIDS and Behavior 24:5, pages 1281-1289.
Crossref
Crossref
Kenneth A. Katz, Andrew J. Park & Julia L. Marcus. (2020) Preexposure Prophylaxis for Human Immunodeficiency Virus Infection for Men Who Have Sex with Men and Transgender Persons:. Dermatologic Clinics 38:2, pages 233-238.
Crossref
Crossref
Melissa B. GilkeyJulia L. MarcusJacob M. GarrellVictoria E. PowellKevin M. MaloneyDouglas S. Krakower. (2019) Using HIV Risk Prediction Tools to Identify Candidates for Pre-Exposure Prophylaxis: Perspectives from Patients and Primary Care Providers. AIDS Patient Care and STDs 33:8, pages 372-378.
Crossref
Crossref
Victoria E. Powell, Kevin M. Gibas, Joshua DuBow & Douglas S. Krakower. (2019) Update on HIV Preexposure Prophylaxis: Effectiveness, Drug Resistance, and Risk Compensation. Current Infectious Disease Reports 21:8.
Crossref
Crossref